Patents Assigned to MitoTek, LLC
  • Publication number: 20130289123
    Abstract: The present invention is directed to methods of modulating the activity of an isoform of manganese superoxide dismutase which is useful for the treatment of diseases such as neurodegenerative diseases and heart failure.
    Type: Application
    Filed: March 28, 2013
    Publication date: October 31, 2013
    Applicant: MitoTek, LLC
    Inventor: Paul Q. Anziano
  • Patent number: 8426644
    Abstract: The present invention is directed to methods of modulating the activity of an isoform of manganese superoxide dismutase which is useful for the treatment of diseases such as neurodegenerative diseases and heart failure.
    Type: Grant
    Filed: June 28, 2011
    Date of Patent: April 23, 2013
    Assignee: MitoTek, LLC
    Inventor: Paul Q. Anziano
  • Patent number: 8324279
    Abstract: The present invention is directed to methods of modulating the activity of an isoform of manganese superoxide dismutase which is useful for the treatment of diseases such as heart failure.
    Type: Grant
    Filed: September 17, 2009
    Date of Patent: December 4, 2012
    Assignee: MitoTek, LLC
    Inventor: Paul Q. Anziano
  • Publication number: 20120059064
    Abstract: The present invention is directed to methods of modulating the activity of an isoform of manganese superoxide dismutase which is useful for the treatment of diseases such as neurodegenerative diseases and heart failure.
    Type: Application
    Filed: June 28, 2011
    Publication date: March 8, 2012
    Applicant: MitoTek, LLC
    Inventor: Paul Q. Anziano
  • Patent number: 7989499
    Abstract: The present invention is directed to methods of modulating the activity of an isoform of manganese superoxide dismutase which is useful for the treatment of diseases such as neurodegenerative diseases and heart failure.
    Type: Grant
    Filed: February 8, 2006
    Date of Patent: August 2, 2011
    Assignee: MitoTek, LLC
    Inventor: Paul Q. Anziano
  • Publication number: 20100028348
    Abstract: The present invention is directed to methods of modulating the activity of an isoform of manganese superoxide dismutase which is useful for the treatment of diseases such as heart failure.
    Type: Application
    Filed: September 17, 2009
    Publication date: February 4, 2010
    Applicant: MITOTEK, LLC
    Inventor: Paul Q. Anziano